Story

Indian Benchmarks Edge Higher as Cement and Insurance Stocks Outperform

ENTHMSVIIDZHZH-TWJAKOHI
Jul 15, 20261 min read
Indian Benchmarks Edge Higher as Cement and Insurance Stocks Outperform

Summary

India's Nifty 50 and BSE Sensex posted modest gains on Wednesday, buoyed by strength in sectors like capital goods and consumer durables, while volatility eased.

Text size
Background

Indian equity benchmarks closed with modest gains on Wednesday, navigating a mixed session as strength in specific sectors helped offset losses in major metal and utility stocks.

At the close of trading, the NSE Nifty 50 index added 0.11%, while the broader BSE Sensex 30 index gained 0.17%, according to data from Investing.com.

Market Internals

Market breadth was positive, indicating more advancing stocks than decliners. On the National Stock Exchange, 1,351 stocks rose while 1,186 fell. Investor sentiment appeared to stabilize, as reflected by a 3.49% drop in the India VIX, a key gauge of expected market volatility, which settled at 13.27.

Sector performance was varied, with notable gains in the Capital Goods, Consumer Durables, and Oil & Gas indexes providing upward momentum for the broader market.

Key Stock Movers

Sample IUX Markets – In-articleAd

Among the Nifty 50 constituents, cement manufacturer UltraTech Cement Ltd. was the day's top performer, surging 2.91%. Other notable gainers included:

  • Eternal Ltd: +2.80%
  • HDFC Life Insurance Company Ltd: +2.16%

Conversely, metal and utility stocks faced downward pressure. Hindalco Industries Ltd. was the session's biggest laggard, falling 2.13%. Other significant decliners included Power Grid Corporation of India Ltd., which dropped 1.96%, and Tata Steel Ltd., which lost 1.61%.

Broader Market Context

In the commodities market, energy prices advanced, with the August contract for WTI Crude oil rising to $80.27 a barrel. In currency markets, the Indian Rupee weakened against the U.S. dollar, with the USD/INR pair trading up 0.32% at 96.51.

Read next

More on Stocks
Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Stocks

Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Sep 20, 2026

Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) has resubmitted its application for a main board listing on the Hong Kong Stock Exchange, aiming to secure a dual listing to access international capital. The company specializes in drugs for central nervous system and cardiovascular diseases.

Back to latest news

LATEST